[ad_1] In a new report from Wintermute, the market maker and liquidity provider, said that its over-the-counter (OTC) volume was up 400% throughout the year as volumes moved off-exchanges. Wintermute…
Tag: OTC
Nigeria’s OTC Securities Exchange Rises 1%
[ad_1] By Adedapo Adesanya The NASD Over-the-Counter (OTC) Securities Exchange recorded a 1.00 per cent appreciation on Tuesday, December 12, with three stocks on the platform closing higher. 11 Plc…
REPLENISH ANNOUNCES Q3 2023 BUSINESS UPDATE, MARKET OUTLOOK AND THIRD QUARTER FINANCIAL RESULTS
[ad_1] /NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES/ CALGARY, AB, Nov. 29, 2023 /CNW/ – Replenish Nutrients Holding Corp. (formerly EarthRenew Inc.)…
FILAMENT HEALTH SIGNS NON-BINDING TERM SHEET FOR CONVERTIBLE NOTE IN CONNECTION WITH PLANNED BUSINESS COMBINATION
[ad_1] VANCOUVER, BC, Nov. 23, 2023 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical–stage natural psychedelic drug development company, today announced that the…
Vitasoy Announces Business Results for 1H FY2023/2024
[ad_1] Financial Highlights 6 months ended 30 September 2023 1H FY2023/24 HK$ Mn 1H FY2022/23 HK$ Mn Change Net of currency impact and COVID-19 related government subsidies Revenue 3,391 3,642 -7 %…
Mirati Therapeutics Receives Approval from the MHRA for KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
[ad_1] SAN DIEGO and ZUG, Switzerland, Nov. 3, 2023 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial stage biotechnology company, today announced the United Kingdom’s Medicines and Healthcare Products Regulatory…
SAP Turns Every Developer Into a Generative AI Developer at SAP TechEd in 2023
[ad_1] SAP Unveils Innovations in Generative AI Application Development and Vector Database Capabilities as Well as New Learning Opportunities for Developers in the Era of AI BANGALORE, India, Nov. 2,…